CompaniesNeuroRecovery Technologies

NeuroRecovery Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

4

As Collaborator

2

Total Enrollment

213

By Status

UNKNOWN: 5COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT01737723
NCT02696746
NCT01737736
NCT02654691
Hover over trial bars to see details

Recent Trials

NCT02654691Collaborator
Chronic Neuropathy Following Chemotherapy
N/ACompleted
63 participants
Started: Jun 30, 2016 · Completed: Jul 1, 2019
NCT01737736Lead Sponsor
Validation of Neurokeeper's Algorithm on Patients Undergoing Carotid Endarterectomy
N/AUnknown
Started: Jun 30, 2013
NCT02696746Collaborator
Painful Channelopathies Study
N/AUnknown
100 participants
Started: Feb 29, 2012
NCT01737723Lead Sponsor
Electroencephalograph for Detection of Acute Ischemic Stroke
N/AUnknown
20 participants
Started: Aug 31, 2011
NCT01737749Lead Sponsor
Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.
N/AUnknown
View all 6 trials →
Funding History (1)
D
Dec 7, 2016
Filing
Related Companies
Gtx Medical
merged